COMP <GO>
ACT vs BRK-B // ALTMAN Z-SCORE & DEBT/EQUITY
Enact Holdings Inc. (NASDAQ) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: ACT 5
— BRK-B 3
■ METRIC PARITY
LAST: $47.18 (-1.83%) • MKT CAP: $6.61B
balance-sheet
—
LAST: $542.49 (+0.10%) • MKT CAP: $1.20T
balance-sheet
2.85
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACT VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACT | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.60% | 11.47% | +1.13 | ACT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 10.97% | 2.09% | +8.88 | ACT | /fcf-yield <GO> |
| Operating Margin | — | 27.80% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 54.60% | 22.30% | +32.30 | ACT | /net-margins <GO> |
| Revenue Growth (YoY) | 2.80% | 3.93% | -1.13 | BRK-B | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.83% | 0.00% | +1.83 | ACT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 2.85 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.3 | 67.7 | -11.40 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.61 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.1x | 24.3x | -15.24 | ACT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.61B | $1.20T | -$1.19T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACT REV | BRK-B REV | ACT GROSS % | BRK-B GROSS % | ACT FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.24B | $371.44B | — | — | $724.5M | $25.04B |
| FY 2024 | $1.20B | $371.43B | — | — | $686.3M | $11.62B |
| FY 2023 | $1.15B | $364.48B | — | — | $632.0M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACT // BETA —
BRK-B // BETA 0.61